Have to ask the dumb questions to learn.
Novartis was going to buy $25m of equity as an early milestone in the Ards study.
Could the issue of these new shares be related to a partnership deal whereby the equity
buy is now up to $180m?
A partnership deal that has yet to be concluded hence no need to update the market.
Something like a global heart partnership
I know nothing, just like the market
Reg
News: MSB Mesoblast Ltd Files For Shelf Of Up To $180 Mln ADS Representing Ordinary Shares, page-69
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.5¢ |
Change
-0.005(0.52%) |
Mkt cap ! $1.090B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | 97.0¢ | 95.0¢ | $339.0K | 354.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 18865 | 95.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 96.0¢ | 58800 | 18 |
View Market Depth
| Last trade - 10.57am 13/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |